BIOGEN INC - ESTIMATED CHARGE TO IMPACT EPS BY ($0.26) PER SHARE FOR Q2 - SEC FILING
BIOGEN INC - EXPECTS $46 MILLION EXPENSE FOR BOUGHT RESEARCH AND DEVELOPMENT IN Q2 2025 - SEC FILING
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.